- Home
- OST vs STRO Comparison
OST vs STRO Comparison
Compare OST & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OST
- STRO
- Stock Information
- Founded
- OST 2010
- STRO 2003
- Country
- OST China
- STRO United States
- Employees
- OST N/A
- STRO N/A
- Industry
- OST Industrial Machinery/Components
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OST Technology
- STRO Health Care
- Exchange
- OST Nasdaq
- STRO Nasdaq
- Market Cap
- OST 51.0M
- STRO 50.0M
- IPO Year
- OST 2022
- STRO 2018
- Fundamental
- Price
- OST $4.14
- STRO $0.87
- Analyst Decision
- OST
- STRO Hold
- Analyst Count
- OST 0
- STRO 8
- Target Price
- OST N/A
- STRO $6.14
- AVG Volume (30 Days)
- OST 6.1M
- STRO 2.3M
- Earning Date
- OST 01-27-2025
- STRO 05-08-2025
- Dividend Yield
- OST N/A
- STRO N/A
- EPS Growth
- OST N/A
- STRO N/A
- EPS
- OST N/A
- STRO N/A
- Revenue
- OST $32,463,213.00
- STRO $62,043,000.00
- Revenue This Year
- OST N/A
- STRO N/A
- Revenue Next Year
- OST N/A
- STRO $1.29
- P/E Ratio
- OST N/A
- STRO N/A
- Revenue Growth
- OST N/A
- STRO N/A
- 52 Week Low
- OST $0.78
- STRO $0.52
- 52 Week High
- OST $5.30
- STRO $5.17
- Technical
- Relative Strength Index (RSI)
- OST 70.42
- STRO 48.53
- Support Level
- OST $2.84
- STRO $0.80
- Resistance Level
- OST $3.39
- STRO $1.11
- Average True Range (ATR)
- OST 0.52
- STRO 0.18
- MACD
- OST 0.16
- STRO 0.02
- Stochastic Oscillator
- OST 91.83
- STRO 41.53
About OST Ostin Technology Group Co. Ltd.
Ostin Technology Group Co Ltd is a supplier of display modules and polarizers in China. It designs, develops, and manufactures TFT-LCD modules in a wide range of sizes and customized sizes according to the specifications of its customers. Its display modules are mainly used in consumer electronics, commercial LCD displays, and automotive displays. The company also manufactures polarizers used in the TFT-LCD display modules and is in the process of developing polarizers for the OLED display panel. Geographically, the company generates revenue from Hong Kong, Taiwan, and Mainland China which is its key revenue generating market.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.